9
article
FasterCures Selects Foundation CEOs for New Cohort of the LeadersLink Program
Advancing a promising scientific discovery to a viable treatment option requires long-term coordinat
ed efforts from leaders across the biomedical ecosystem.
+ Read More
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More
article
Medicare Drug Price Negotiation Program comment letter
Submitted electronically
Dr. Meena Seshamani
Deputy Administrator and Director, Center for Medicare
Centers for Medicare & Medicaid Services
US Department of Health and Human Services
Baltimore, MD 21244
+ Read More
article
FasterCures Quarterly Update: July 2022
It has been a busy year so far for the FasterCures team as we advance programs to lower unnecessary
barriers to progress and accelerate biomedical innovations to all patients.
+ Read More
article
An Update from MI Health—July 2024
In This Issue:
article
Center for Public Health Newsletter: Spring 2022
We are excited to launch our first Milken Institute Center for Public Health (CPH) newsletter to our
community and look forward to keeping you updated on the prog
+ Read More
article
FasterCures Quarterly Update: July 2023
In This Issue:
Convenings Recap
Policy Updates
FasterCures in the Media
FasterCures in the Communit
y
+ Read More
article
FasterCures Quarterly Update: October 2022
In This Issue:
Advancing Health Equity in Biomedical Research
FasterCures Roundtables Recap
Policy
Update
+ Read More
article
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US Senate HELP Committee
Submitted electronically